Deductibles

You are currently browsing articles tagged Deductibles.

Merrill Goozner of GoozNews writes the following:

The share of health care costs borne by individuals has remained fairly steady over the past several decades, and that is the prime argument behind conservative and economist claims that making patients have “more skin in the game” will drive health care costs lower. That ignores the fact that most people (except those in some union plans) have experienced fast rising co-pays and deductibles for years. As health care inflation skyrocketed, employer-paid premiums skyrocketed. But so did individual payments in equal proportion. Where’s the evidence that the skyrocketing co-payments of the past decade held down health care costs?

Do higher copayments hold down health care costs?  In general, the answer is YES.  As Mr. Goozner has mentioned, there has been much evidence by economists that when patients pay more money out of their own pocket, they consume less medical care.  The RAND health insurance experiment finds this to be true in the strongest terms.

However, there are exceptions. For instance, higher co-payments on pharmaceuticals will decrease drug use, but lower pharmaceutical adherence may increase hospitalization rates thus increasing healthcare spending. This is a problem of how to design the insurance contract, not a violation of the central tenet of moral hazard (i.e., when someone else pays for a good, you will consume more of it).  In fact, I have written extensively on the issue of moral hazard.

Additionally, on a macro level, the majority of health care costs come from serious, end-of-life care. In these situations, the physician has much more control over the services provided than the patient.  Further, once a person has reached this stage, the copayments are likely small as the deductible has already been met.

The major problem with Mr. Goozner’s argument is that he does not distinguish between correlation and causation.  In recent history, copayments have increased and so have costs, but this does not mean that higher copayments caused the increased costs or even that they did little to stem the tide of cost increases.  Health care has changed on many dimensions including medical technology, how doctors treat patients, hospital and provider consolidation, etc.  The counterfactual against which one should measure the impact of higher copayments is the following scenario: what if all the exact same changes took place in recent history but copayments did not change over time.  How different would costs be from our current state?  Likely, healthcare care costs would have risen even faster than without the increased copayments.  Nevertheless, since one can never redo the past, this exercise is simply a thought experiment.

Logically, however, it makes sense that higher copayments and deductibles decrease medical costs.  If you go to the dentist and they want you to pay a few hundred dollars for an x-ray, you will be much more likely to acquiesce if your insurance is paying for the x-ray rather than it is coming out of your own pocket.

Higher copayments do decrease medical utilization, but they are just one of many factors that influence aggregate healthcare costs.

Tags: , , ,

In this blog, I have written about the Swiss (part one, part two) and Dutch healthcare system extensively. Both systems have a “regulated competition” where insurance is mandatory and insurance companies are mandated to provide a specific insurance benefit package. In the Swiss system, 85% of medical expenditures are financed by insurance premiums and 15% are financed by user fees. In the Netherlands, 50% of expenditures are paid by income-related contributions, 45% are paid by insurance premiums and 5% are paid by user fees. In both systems, the government pays a risk equalization premium to insurance companies who have a higher percentage of sick people to help eliminate cream skimming. However, does this risk equalization system still function when voluntary deductibles are introduced?

This is the question which a paper by van Kleef, et al. (2008) attempt to answer. Currently, the Swiss only count net claims (medical claims paid by the insurance company, ignoring out-of-pocket payments by insurers). Is this a problem? Let us give one example:

Let us assume that Healthy Hank spends $1000 on health care per year and is insured by HealthNet and Sick Sally spends $2000 on health care per year and is insured by SickFund. In the Swiss system, insurance companies receive (pay) a risk equalization payment based on whether they have above (below) average medical expenditures. This would mean that insurance premiums would be $1500, the average of Hank and Sally’s expenditures. HealthNet would pay $500 into the risk equalization pool and SickFund would receive $500.

What happens in the presence of deductibles? Let us assume that HealthNet offers an insurance package with a $500 deductible and HealthNet offers an insurance package with no deductible. Healthy Hanks will sort into the HealthNet deductible package and Sick Sallys sort into the no deductible SickFund package. Now, we have that HealthNet will have $500 of net claims on average since Hank will pay $500 and the insurance company will pay $500. SickFund will still have $2000 of cost.

Now the insurance premium will be $1250 since the insurance premium is based on net claims [(2000+500)/2]. HealthNet will have risk equalization payment of $750 and SickFund will receive $750. The insurance premium for Healthy Harry will be $1250 ($500 + the $750 equalization payment) . The premium for SickFund will be $1250 as well ($2000-the $750 risk equalization payment). Thus, there will be no benefit to choosing the deductible since there is no premium benefit. Yet policy makers would like people to choose the deductible plan to reduce moral hazard. The paper gives a few other scenarios where the risk equalization scheme fails and cream skimming occurs.

In general, economist love choice. Yet in insurance markets, the more choice is given to consumers, the more incentive insurance companies have to cream skim. Despite policymakers best attempts to control cream skimming through risk equalization payments, no risk equalization scheme will be perfect. Like everything in life, there is a tradeoff. In this case, the tradeoff is between offering consumers more choice, and reducing cream-skimming.

Tags: , , , ,